Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma

Blood (2015) 126 (8): 950–956.

https://doi.org/10.1182/blood-2014-12-616474

Published: 2015

Includes: Supplemental data

Journal Articles

Weekly Infusion of Bortezomib In Combination with Rituximab In Relapsed/Refractory Indolent Non-Follicular and Mantle Cell Lymphoma Is Safe and Effective: Two-Years Analysis of Phase II Trial BRIL06 of Intergruppo Italiano Linfomi (IIL)

Annalisa Chiappella, Patrizia Pregno, Pier Luigi Zinzani, Andrea Evangelista, Alberto Fabbri, Fabio Facchetti, Andres JM Ferreri, Silvia Franceschetti, Roberto Freilone, Livio Gargantini, Daniela Gioia, Anna Marina Liberati, Maura Nicolosi, Lorella Orsucci, Luigi Rigacci, Eleonora Russo, Vittorio Stefoni, Alessandra Tucci, Umberto Vitolo

Blood (2010) 116 (21): 3965.

https://doi.org/10.1182/blood.V116.21.3965.3965

Published: 2010

Journal Articles

Salvage Treatment with Lenalidomide and Dexamethasone in Patients with Relapsed Refractory Mantle Cell Lymphoma.

Blood (2009) 114 (22): 1713.

https://doi.org/10.1182/blood.V114.22.1713.1713

Published: 2009

Journal Articles

The Combination of Bortezomib and Rituximab Is Effective and Safe in Relapsed/Refractory Indolent Non Follicular and Mantle-Cell Non Hodgkin Lymphoma: a Phase II Multicenter Study by Intergruppo Italiano Linfomi.

Annalisa Chiappella, Patrizia Pregno, Pier Luigi Zinzani, Fabio Facchetti, Andrea Evangelista, Alberto Fabbri, Andres JM Ferreri, Silvia Franceschetti, Roberto Freilone, Livio Gargantini, Daniela Gioia, Anna Marina Liberati, Lorella Orsucci, Luigi Rigacci, Eleonora Russo, Vittorio Stefoni, Alessandra Tucci, Umberto Vitolo

Blood (2009) 114 (22): 3758.

https://doi.org/10.1182/blood.V114.22.3758.3758

Published: 2009

Journal Articles

FDG-PET for Staging and Follow-up of HIV-Infected Patients with Non Hodgkin Lymphoma and Hodgkin Lymphoma: A Single Center Experience.

Silvia Cantoni, MD, Erika Ravelli, MD, Maria Cristina Moioli, MD, Chiara Rusconi, MD, Vittorio Ruggero Zilioli, MD, Claudia Maria Basilico, MD, Livio Gargantini, MD, Annamaria Nosari, MD, Alberto Volonterio, MD, Claudio Rossetti, MD, Enrica Morra, MD

Blood (2009) 114 (22): 5014.

https://doi.org/10.1182/blood.V114.22.5014.5014

Published: 2009

Journal Articles

Reinforced Mini-BEAM Followed by Autologous Hematopoietic Stem Cell Infusion in Refractory Lymphoma: A Study of Feasibility and Efficacy

Chiara Rusconi, MD, Anna Maria Nosari, MD, Chiara Vanelli, MD, Vittorio Ruggero Zilioli, MD, Erika Ravelli, MD, Claudia Maria Basilico, MD, Livio Gargantini, MD, Laura Marbello, MD, Alfredo Molteni, MD, Giovanni Grillo, MD, Enrica Morra

Blood (2008) 112 (11): 4437.

https://doi.org/10.1182/blood.V112.11.4437.4437

Published: 2008

Journal Articles

Utility of FDG-PET in Post Transplant Lymphoproliferative Disorders: An Update from a Single Center Experience

Erika Ravelli, MD, Valentina Mancini, MD, Livio Gargantini, MD, Chiara Rusconi, MD, Claudia Maria Basilico, MD, Mauro Turrini, MD, Vittorio Ruggiero Zilioli, MD, Denis Ciapanna, MD, Giuliana Muti, MD, Claudio Rossetti, MD, Annamaria Nosari, MD, Enrica Morra, MD

Blood (2008) 112 (11): 5266.

https://doi.org/10.1182/blood.V112.11.5266.5266

Published: 2008

Journal Articles

Skeletal Involvement in Advanced Stage Lymphomas: Role of Total Body Magnetic Resonance.

Chiara Rusconi, MD, Erika Ravelli, MD, Livio Gargantini, MD, Francesca Ganguzza, MD, Denis Ciapanna, MD, Cristiana Ticca, MD, Mauro Turrini, MD, Gianbattista Bertani, MD, Angelo Vanzulli, MD, Enrica Morra, MD

Blood (2007) 110 (11): 4405.

https://doi.org/10.1182/blood.V110.11.4405.4405

Published: 2007

Journal Articles

Transient Massive Lymphoid Bone Marrow Infiltrate Developing during Therapy with the Tyrosine Kinase Inhibitors Imatinib and Nilotinib: Report of 2 Patients.

Ester Pungolino, MD, Silvia Cantoni, MD, Cecilia Del Curto, MD, Livio Gargantini, MD, Marianna Caramella, MD, Sara Miqueleiz, MD, Alessandra Tedeschi, MD, Michela Draisci, MD, Cristina Gabutti, MD, Simona Paratore, MD, Karen Lanza, BD, Sonia Ribera, MD, Enrica Morra, MD

Blood (2007) 110 (11): 4577.

https://doi.org/10.1182/blood.V110.11.4577.4577

Published: 2007

Journal Articles

Portal Vein Thrombosis Following Splenectomy for Hematologic Diseases: Prevalence and Risk Factors.

Denis Ciapanna, MD, Annamaria Nosari, MD, Livio Gargantini, MD, Giovanni Mostarda, MD, Michele Nichelatti, MSc, Mauro Turrini, MD, Enrica Morra, MD

Blood (2006) 108 (11): 1498.

https://doi.org/10.1182/blood.V108.11.1498.1498

Published: 2006

Journal Articles

Unexpectedly High Incidence of Interstitial Pneumonia in Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with Rituximab-CHOP-14 Supported with Pegfilgrastim.

Ercole Brusamolino, MD, Chiara Rusconi, MD, Luigi Montalbetti, MD, Livio Gargantini, MD, Graziella Pinotti, MD, Lilj Uziel, MD, Sergio Fava, MD, Luigi Rigacci, MD, Guido Pagnucco, MD, Guido Frigerio, MD, Mario Fiumano, MD, Luciano Banfi, MD, Francesco Rodeghiero, MD, Giovanni Ucci, MD, Alberto De Paoli, MD, Giuseppe Attardo Parrinello, MD, Enrica Morra, MD, Mario Lazzarino, MD

Blood (2005) 106 (11): 3330.

https://doi.org/10.1182/blood.V106.11.3330.3330

Published: 2005

Journal Articles

CHOP Chemotherapy Plus Campath-1H (CHOP-C) as First Line Treatment in Patients with Peripheral T-Cell Lymphoma (PTCL).

Andrea Gallamini, Francesco Zaja, Livio Gargantini, Annunziata Manna, Vincenzo Secondo, Alessandro Levis, Luigi Rigacci, Patrizio Mazza, Emilio Iannitto, Antonello Pinto, Alessandra Tucci, Caterina Patti, Valerio Zoli, PierFederico Torchio

Blood (2005) 106 (11): 3345.

https://doi.org/10.1182/blood.V106.11.3345.3345

Published: 2005

Journal Articles

Osteonecrosis of the Jaw Associated with Chronic Bisphosphonates Therapy: An Italian Experience.

Anna M. Cafro, MD, Luciana A. Barbarano, MD, Alessandro Andriani, MD, Giovanna D’Avanzo, MD, Michele Nichelatti, PhD, Domenico Gaglioti, MD, Alberto Taroni, MD, Livio Gargantini, MD, Michela G. Draisci, MD, Enrica Morra, MD

Blood (2005) 106 (11): 5152.

https://doi.org/10.1182/blood.V106.11.5152.5152

Published: 2005

Journal Articles

Good Efficacy of Single Dose PEG-Filgrastim in Enhancing the Mobilization of CD34+ Peripheral Blood Stem Cells (PBSC) in Aggressive Lymphoma Patients Treated with Cisplatin-Containing Regimens.

Annamaria Nosari, MD, Claudia Baraté, MD, Liliana Intropido, PhD, Denis Ciapanna, MD, Roberto Cairoli, MD, Livio Gargantini, MD, Laura Pezzetti, PhD, Valentina Mancini, MD, Erica Ravelli, MD, Francesca Ricci, MD, Roberto Ripamonti, PhD, Enrica Morra, MD

Blood (2005) 106 (11): 4265.

https://doi.org/10.1182/blood.V106.11.4265.4265

Published: 2005

Journal Articles

Mobilization of Ph-Negative Peripheral Blood Stem Cells (PBSCs) with rHu-G-CSF in Chronic Myeloid Leukemia (CML) Patients Achieving Complete Cytogenetic Response with Imatinib Mesilate (Glivec).

Ester Pungolino, MD, Michela Draisci, MD, Livio Gargantini, MD, Renata Farioli, PhD, Valentina Rossi, MD, Paola Cozzi, MD, Sara Miqueleiz Alamos, MD, Anna Maria Cafro, MD, Enrica Morra, MD

Blood (2004) 104 (11): 4690.

https://doi.org/10.1182/blood.V104.11.4690.4690

Published: 2004

Journal Articles

Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma

Blood (2002) 99 (3): 856–862.

https://doi.org/10.1182/blood.V99.3.856

Published: 2002

NARROW

Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma

Weekly Infusion of Bortezomib In Combination with Rituximab In Relapsed/Refractory Indolent Non-Follicular and Mantle Cell Lymphoma Is Safe and Effective: Two-Years Analysis of Phase II Trial BRIL06 of Intergruppo Italiano Linfomi (IIL)

Salvage Treatment with Lenalidomide and Dexamethasone in Patients with Relapsed Refractory Mantle Cell Lymphoma.

The Combination of Bortezomib and Rituximab Is Effective and Safe in Relapsed/Refractory Indolent Non Follicular and Mantle-Cell Non Hodgkin Lymphoma: a Phase II Multicenter Study by Intergruppo Italiano Linfomi.

FDG-PET for Staging and Follow-up of HIV-Infected Patients with Non Hodgkin Lymphoma and Hodgkin Lymphoma: A Single Center Experience.

Reinforced Mini-BEAM Followed by Autologous Hematopoietic Stem Cell Infusion in Refractory Lymphoma: A Study of Feasibility and Efficacy

Utility of FDG-PET in Post Transplant Lymphoproliferative Disorders: An Update from a Single Center Experience

Skeletal Involvement in Advanced Stage Lymphomas: Role of Total Body Magnetic Resonance.

Transient Massive Lymphoid Bone Marrow Infiltrate Developing during Therapy with the Tyrosine Kinase Inhibitors Imatinib and Nilotinib: Report of 2 Patients.

Portal Vein Thrombosis Following Splenectomy for Hematologic Diseases: Prevalence and Risk Factors.

Unexpectedly High Incidence of Interstitial Pneumonia in Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with Rituximab-CHOP-14 Supported with Pegfilgrastim.

CHOP Chemotherapy Plus Campath-1H (CHOP-C) as First Line Treatment in Patients with Peripheral T-Cell Lymphoma (PTCL).

Osteonecrosis of the Jaw Associated with Chronic Bisphosphonates Therapy: An Italian Experience.

Good Efficacy of Single Dose PEG-Filgrastim in Enhancing the Mobilization of CD34+ Peripheral Blood Stem Cells (PBSC) in Aggressive Lymphoma Patients Treated with Cisplatin-Containing Regimens.

Mobilization of Ph-Negative Peripheral Blood Stem Cells (PBSCs) with rHu-G-CSF in Chronic Myeloid Leukemia (CML) Patients Achieving Complete Cytogenetic Response with Imatinib Mesilate (Glivec).

Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only